Genomtec

Genomtec EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomtec (GMT.WA) as of Nov 10, 2026 is -14.78 M PLN. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -11.06 M PLN — a change of 33.68% (lower).

EBITDA

-14.78 MPLN

YoY

33.68%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomtec is 2025 -14.78 M PLN. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomtec was 2024 -11.06 M PLN. It decreases by 33.68% lower compared to the previous year.

The Genomtec EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-1.25 M PLN
Jan 1, 2019
-2.75 M PLN
Jan 1, 2020
-14.48 M PLN
Jan 1, 2021
-10.22 M PLN
Jan 1, 2022
-11.95 M PLN
Jan 1, 2023
-8.73 M PLN
Jan 1, 2024
-11.06 M PLN
Jan 1, 2025
-14.78 M PLN
The Genomtec EBITDA history
YEAREBITDAYoY
-14.78 MPLN+33.68%
-11.06 MPLN+26.68%
-8.73 MPLN-26.99%
-11.95 MPLN+16.97%
-10.22 MPLN-29.43%
-14.48 MPLN+427.01%
-2.75 MPLN+120.49%
-1.25 MPLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Genomtec Stock analysis

What does Genomtec do? Genomtec SA generates revenue by researching and developing molecular diagnostic equipment, specifically focusing on the Genomtec ID mobile platform. This technology enables genetic diagnosis at the point of patient care, eliminating the need for complex laboratory workflows and qualified personnel. The platform is designed for use in primary care clinics, pharmacies, doctor’s offices, and hospital emergency departments. Genomtec is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Genomtec stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomtec is -14.78 M PLN in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Genomtec changed from -11.06 M PLN to -14.78 M PLN, representing a 33.68% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Genomtec since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Genomtec historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Genomtec

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Genomtec